LifeMD climbs after launching at-home cancer test kits

LifeMD

14/09/2022 14:59

** Shares of telehealth service provider LifeMD Inc  LFMD.O 
up 5% at $2.69 in early trade 
    ** Co launches at-home, self-testing kits to detect
early-stage breast cancer and colon cancer  urn:newsml:reuters.com:*:nGNX1HPjnc
    ** Kits developed by Biomerica Inc  BMRA.O , which in July
also partnered with Walmart Inc  WMT.N  to make those kits
available for sale via the retailers' stores  urn:newsml:reuters.com:*:nFWN2YV1F9
    ** YTD, LFMD has fallen 33.85%

 (Reporting by Anirban Chakroborti in Bengaluru)
 ((Anirban.Chakroborti@thomsonreuters.com))